IDE-2 is primarily utilized in research focused on regenerative medicine and diabetes treatment. It functions as a small molecule inhibitor that specifically targets the TGF-β signaling pathway, which plays a crucial role in cell differentiation and proliferation. By modulating this pathway, IDE-2 has shown potential in promoting the differentiation of stem cells into insulin-producing pancreatic beta cells. This application is particularly significant in developing therapies for Type 1 diabetes, where the destruction of beta cells leads to insulin deficiency. Additionally, IDE-2 is employed in studies exploring tissue repair and regeneration, as it influences cellular processes essential for healing and growth. Its ability to precisely control cell differentiation makes it a valuable tool in advancing stem cell research and therapeutic strategies.